An interventional study of Air purifier and fresh air ventilation systems with high-efficiency particulate air (HEPA) filters and Air purifier and fresh air ventilation systems without high-efficiency particulate air (HEPA) filters in Cardiopulmonary Function and Child, sponsored by Fudan University. Active, not recruiting at 1 site in China. Open to participants aged 8 Years to 12 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-02.
Sponsored by Fudan University · Not applicable, Interventional, and Prevention
This study aims to explore changes in cardiopulmonary function and other health indicators in primary school students with the intervention of air purifiers on a randomized controlled trial.
The investigators will conduct a randomized controlled trial among 110 healthy children in Jiaozuo city, Henan, China. The eligible children will be divided into two groups according to their classes and randomly receive interventions of either true or sham air purifiers. The air purifiers devices in classroom [air purifiers and fresh air ventilation systems] will operate during the school time and the devices in bedrooms (air purifiers) operate during the home time in the intervention period. All the participants and investigators will be blinded to the group assignment. Epidemiological questionnaires (i.e., basic characteristics, eating habits, daily schedule, etc.) will be conducted and health indicators (i.e., blood pressure, pulmonary function indicators, fractional exhaled nitric oxide, and fractional exhaled carbon monoxide) and biological specimens (i.e., morning urine, venous blood, exhaled breath condensate, and feces) will be evaluated and collected at baseline and after the completion of intervention period (4 months anticipated).
Fudan University is the lead sponsor of 1,270 studies on the registry; 623 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Children in this group will receive an intervention of air purifiers with high-efficiency particulate air (HEPA) filters.
Behavioral: Air purifier and fresh air ventilation systems with high-efficiency particulate air (HEPA) filters
Children in this group will receive an intervention of air purifiers without high-efficiency particulate air (HEPA) filters.
Behavioral: Air purifier and fresh air ventilation systems without high-efficiency particulate air (HEPA) filters
This group will receive an intervention of true air purifiers. The air purifiers in classroom (air purifiers and fresh air ventilation systems with HEPA filters) will operate during the school time and the air purifiers in bedrooms (air purifiers with HEPA filters) operate during the home time in the intervention period (4 months anticipated).
This group will receive an intervention of sham air purifiers. The air purifiers in classroom (air purifiers and fresh air ventilation systems without HEPA filters) will operate during the school time and the air purifiers in bedrooms (air purifiers without HEPA filters) operate during the home time in the intervention period (4 months anticipated).
Changes of heart rate variability
Nihon Kohden Electrocardiograph and Carepatch Electrocardiogram are used to measure heart rate variability, including standard deviation of all normal-to-normal R-R intervals (SDNN), standard deviation of sequential five-minute R-R interval means (SDANN), root-mean-square difference of successive normal R-R intervals (RMSSD), low frequency (LF), and high frequency (HF) in intervention and control groups. To eliminate possible errors, measurements are conducted by the same trained staff using the same instrument.
Time frame: Baseline and after the completion of intervention period (4 months anticipated)
Changes of forced expiratory volume in 1 s (FEV1)
The pulmonary function measures are performed by the professional medical device. Before the pulmonary function test, subjects practice several times with the guidance of professional staff. During the examination, each subject in a sitting position and clamp the nose clip, and repeat the test, with the best result as the criterion.
Time frame: Baseline and after the completion of intervention period (4 months anticipated)
Changes of forced vital capacity (FVC)
The pulmonary function measures are performed by the professional medical device. Before the pulmonary function test, subjects practice several times with the guidance of professional staff. During the examination, each subject in a sitting position and clamp the nose clip, and repeat the test, with the best result as the criterion.
Time frame: Baseline and after the completion of intervention period (4 months anticipated)
Changes of forced expiratory volume in 1 s (FEV1) / forced vital capacity (FVC) ratio
The pulmonary function measures are performed by the professional medical device. Before the pulmonary function test, subjects practice several times with the guidance of professional staff. During the examination, each subject in a sitting position and clamp the nose clip, and repeat the test, with the best result as the criterion.
Time frame: Baseline and after the completion of intervention period (4 months anticipated)
Changes of peak expiratory flow (PEF)
The pulmonary function measures are performed by the professional medical device. Before the pulmonary function test, subjects practice several times with the guidance of professional staff. During the examination, each subject in a sitting position and clamp the nose clip, and repeat the test, with the best result as the criterion.
Time frame: Baseline and after the completion of intervention period (4 months anticipated)
Changes of fractional exhaled nitric oxide (FeNO) levels
A NIOX VERO Sensor is used to measure fractional exhaled nitric oxide (FeNO) as a biomarker for airway inflammation. After deep breathing, the subjects gently inhaled into the device. The instrument shows FeNO level of the subjects.
Time frame: Baseline and after the completion of intervention period (4 months anticipated)
Changes of fractional exhaled carbon monoxide (FeCO) levels
Use PICO to measure fractional exhaled carbon monoxide (FeCO) as a biomarker for cardiovascular risk. After deep breathing and holding the breath for 15 seconds, the subjects gently inhaled into the device. The instrument shows FeCO level of the subjects.
Time frame: Baseline and after the completion of intervention period (4 months anticipated)
Changes of blood pressure
Using Omron blood pressure monitor to measure the systolic blood pressure (SBP), diastolic blood pressure (DBP), and pulse pressure for each subject by the trained staff using the same instrument.
Time frame: Baseline and after the completion of intervention period (4 months anticipated)
Changes of C-reactive protein (CRP)
Detect the concentration of C-reactive protein (CRP) in blood sample to examine the different level of inflammation between the groups of intervention and control.
Time frame: Baseline and after the completion of intervention period (4 months anticipated)
Changes of 8-hydroxydeoxyguanosine (8-OHdG)
Detect the concentration of 8-hydroxydeoxyguanosine (8-OHdG) in urine sample of groups of intervention and control. 8-OHdG is a biomarker for DNA oxidative damage.
Time frame: Baseline and after the completion of intervention period (4 months anticipated)
Changes of persistent response (PR)
Examine persistent response (PR) as the index to test the focus ability of children. The test is performed by the Wisconsin Card Sorting Test (WCST) through a computer, and the index reflects the ability of cognitive transfer. The normal value is less than or equal to 27.
Time frame: Baseline and after the completion of intervention period (4 months anticipated)
Differences in metabolite levels detected in metabolomics between groups of intervention and control.
Mass spectrometry-based serum metabolomics is non-targeted. The study is to explore the differential metabolites in blood/urine/exhaled breath condensate (EBC) samples of the groups of intervention and control.
Time frame: Baseline and after the completion of intervention period (4 months anticipated)
Plan to share: Undecided
No publications or documents are linked to this record.
This study is active, not recruiting, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Fudan University